RedDress received 510(k) clearance for its wound care device, which allows health care providers to produce whole blood clots.

The device is intended to be used at point-of-care, using the patient’s own peripheral blood to clot wounds.

Under professional supervision, the blood clot produced by the system is topically applied to manage exuding cutaneous wound such as ulcers and mechanically or surgically-debrided wounds.